These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32122381)

  • 1. MRI response rate after short-course radiotherapy on rectal cancer in the elderly comorbid patient: results from a retrospective cohort study.
    Koëter T; van Elderen SGC; van Tilborg GFAJB; de Wilt JHW; Wasowicz DK; Rozema T; Zimmerman DDE
    Radiat Oncol; 2020 Mar; 15(1):53. PubMed ID: 32122381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Findings in magnetic resonance imaging for restaging locally advanced rectal cancer.
    Marjasuo S; Koskenvuo L; Lepistö A
    Int J Colorectal Dis; 2024 Jan; 39(1):23. PubMed ID: 38289485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes.
    Detering R; Borstlap WAA; Broeders L; Hermus L; Marijnen CAM; Beets-Tan RGH; Bemelman WA; van Westreenen HL; Tanis PJ;
    Ann Surg Oncol; 2019 Feb; 26(2):437-448. PubMed ID: 30547330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short course radiotherapy and delayed surgery for locally advanced rectal cancer in frail patients: is it a valid option?
    Lancellotti F; Solinas L; Sagnotta A; Mancini S; Cosentino LPM; Belardi A; Battaglia B; Mirri MA; Ciabattoni A; Salerno F; Loponte M
    Eur J Surg Oncol; 2021 Aug; 47(8):2046-2052. PubMed ID: 33757649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
    Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
    Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
    Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
    Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.
    Simillis C; Khatri A; Dai N; Afxentiou T; Jephcott C; Smith S; Jadon R; Papamichael D; Khan J; Powar MP; Fearnhead NS; Wheeler J; Davies J
    Crit Rev Oncol Hematol; 2023 Mar; 183():103927. PubMed ID: 36706968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose escalation of preoperative short-course radiotherapy followed by neoadjuvant chemotherapy in locally advanced rectal cancer: protocol for an open-label, single-centre, phase I clinical trial.
    Zhang MX; Li XB; Guan BJ; Guan GX; Lin XY; Wu XD; Chi P; Xu BH
    BMJ Open; 2019 Mar; 9(3):e025944. PubMed ID: 30904869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial magnetic resonance imaging tumour regression grade (mrTRG) as response evaluation after neoadjuvant treatment predicts sustained complete response in patients with rectal cancer.
    Suzuki C; Halperin SK; Nilsson PJ; Martling A; Holm T
    Eur J Surg Oncol; 2022 Jul; 48(7):1643-1649. PubMed ID: 35272899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients.
    Cho MS; Kim H; Han YD; Hur H; Min BS; Baik SH; Cheon JH; Lim JS; Lee KY; Kim NK
    Medicine (Baltimore); 2019 Aug; 98(35):e16614. PubMed ID: 31464897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI demonstration of the effect of neoadjuvant radiotherapy on rectal carcinoma.
    Jacques AE; Rockall AG; Alijani M; Hughes J; Babar S; Aleong JA; Cottrill C; Dorudi S; Reznek RH
    Acta Oncol; 2007; 46(7):989-95. PubMed ID: 17851843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient- and physician-reported radiation-induced toxicity of short-course radiotherapy with a prolonged interval to surgery for rectal cancer.
    Verweij ME; Hoendervangers S; von Hebel CM; Pronk A; Schiphorst AHW; Consten ECJ; Smits AB; Heikens JT; Verdaasdonk EGG; Rozema T; Verkooijen HM; van Grevenstein WMU; Intven MPW
    Colorectal Dis; 2023 Jan; 25(1):24-30. PubMed ID: 36054676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of neoadjuvant short-course radiotherapy and delayed surgery versus chemoradiation on postoperative outcomes in locally advanced rectal cancer patients - A propensity score matched nationwide audit-based study.
    Hoendervangers S; Sparreboom CL; Intven MPW; Lange JF; Verkooijen HM; Doornebosch PG; van Grevenstein WMU;
    Eur J Surg Oncol; 2020 Sep; 46(9):1605-1612. PubMed ID: 32192792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pathological response of standard chemoradiotherapy versus short course radiotherapy in rectal carcinoma: A pilot study.
    Nagarjun BR; Shah A; Gami A; Gandhi J; Parikh A; Modi V
    Indian J Pathol Microbiol; 2023; 66(4):708-713. PubMed ID: 38084520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.
    Sclafani F; Brown G; Cunningham D; Wotherspoon A; Mendes LST; Balyasnikova S; Evans J; Peckitt C; Begum R; Tait D; Tabernero J; Glimelius B; Roselló S; Thomas J; Oates J; Chau I
    Br J Cancer; 2017 Nov; 117(10):1478-1485. PubMed ID: 28934761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-Term Outcomes and Cost-Effectiveness between Long-Course Chemoradiation and Short-Course Radiotherapy for Locally Advanced Rectal Cancer.
    Cho MS; Bae HW; Chang JS; Yang SY; Kim TH; Koom WS; Shin SJ; Choi GS; Kim NK
    Yonsei Med J; 2023 Jun; 64(6):395-403. PubMed ID: 37226566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 19. Preoperative short-course radiotherapy followed by consolidation chemotherapy for treatment with locally advanced rectal cancer: a meta-analysis.
    Wu H; Fan C; Fang C; Huang L; Li Y; Zhou Z
    Radiat Oncol; 2022 Jan; 17(1):14. PubMed ID: 35073940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidisciplinary discussion and management of rectal cancer: a population-based study.
    Swellengrebel HA; Peters EG; Cats A; Visser O; Blaauwgeers HG; Verwaal VJ; van Velthuysen ML; Cense HA; Bruin SC; Marijnen CA
    World J Surg; 2011 Sep; 35(9):2125-33. PubMed ID: 21720869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.